BIOMARIN PHARMACEUTICAL INC

NASDAQ: BMRN (BioMarin Pharmaceutical Inc.)

Last update: 07 Apr, 4:05AM

86.95

0.06 (0.07%)

Market Trend

Short Term Medium Term
Industry Biotechnology (US) Bullish Bullish
Biotechnology (Global) Bullish Bullish
Stock BioMarin Pharmaceutical Inc. - -

BioMarin's focus is on rare-disease therapies. Genzyme (now part of Sanofi) markets Aldurazyme through its joint venture with BioMarin, and BioMarin markets Naglazyme, Vimizim, and Brineura independently. BioMarin also markets Kuvan and Palynziq to treat the rare metabolic disorder PKU. Voxzogo (vosoritide) was approved in achondroplasia in 2021. BioMarin's Roctavian (hemophilia A gene therapy) was approved in Europe in 2022 and in the US in 2023.

Sector Healthcare
Industry Biotechnology
Investment Style Mid Growth
52 Weeks Range
76.02 - 100.38
Price Target Range
91.00 - 107.00
High 107.00 (Piper Sandler, 23.06%) Overweight
Median 100.00 (15.01%)
Low 91.00 (Canaccord Genuity, 4.66%) Hold
Average 100.40 (15.47%)
Total 1 Hold, 1 Sector Perform, 2 Overweight, 1 Outperform
Firm Date Target Price Call Price @ Call
Canaccord Genuity 29 Feb 2024 91.00 (4.66%) Hold 86.28
Cantor Fitzgerald 23 Feb 2024 100.00 (15.01%) Overweight 91.24
Piper Sandler 23 Feb 2024 107.00 (23.06%) Overweight 91.24
RBC Capital 23 Feb 2024 100.00 (15.01%) Sector Perform 91.24
Baird 30 Jan 2024 104.00 (19.61%) Outperform 89.62
Name Avg. Buy ($) Avg. Sell ($) Net Quantity Net Value ($)
BIENAIME JEAN JACQUES - 91.84 -40,000 -3,673,600
BURKHART ERIN - 90.21 -2,286 -206,220
Aggregate Net Quantity -42,286
Aggregate Net Value ($) -3,879,820
Aggregate Avg. Buy ($) -
Aggregate Avg. Sell ($) 91.30
Name Holder Date Type Quantity Price Value ($)
BIENAIME JEAN JACQUES Director 12 Apr 2024 Automatic sell (-) 20,000 92.22 1,844,400
BIENAIME JEAN JACQUES Director 12 Apr 2024 Option execute 20,000 - -
BIENAIME JEAN JACQUES Director 11 Apr 2024 Automatic sell (-) 20,000 91.46 1,829,200
BIENAIME JEAN JACQUES Director 11 Apr 2024 Option execute 20,000 - -
BURKHART ERIN Officer 10 Apr 2024 Automatic sell (-) 2,286 90.21 206,220

Portfolio

Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2024 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No data